| Customers: Federal Scientific Center for Research and Development of Immunobiological Drugs named after M.P. Chumakov RAS Pharmaceuticals, medicine, healthcare Contractors: Mechnikov, LBP Product: COVID-19 coronavirus vaccineProject date: 2021/10
|
During the VI International Congress of Russia-Nicaragua "World after the Pandemic: Directions for the Development of the Pharmaceutical Industry," held in Managua on October 18-21, 2021, the launch of the production of the CoviVak vaccine in Nicaragua was announced. The corresponding agreement was concluded by the developer of the drug FSBNU "FNCIRIP named after M.P. Chumakova RAS" and the Russian-Nicaraguan joint venture LBP Mechnikov.
The first test lots should be released in the near future, the press service of the Ministry of Industry and Trade said on October 23, 2021.
The fact that the Nicaraguan authorities are interested in the production of CoviVaka, Russian Foreign Minister Sergey Lavrov spoke in July 2021. Then he noted that this is a difficult issue, since the company is focused on the production of flu vaccines, and its capacities are loaded with these drugs, which are supplied not only to Nicaragua, but also to Venezuela, Cuba, and Ecuador. About 30 million doses per season of the flu epidemic is produced by this enterprise, Lavrov explained.
He also noted that by July 2021, the production capacities of the Chumakov Center are not yet very significant, and the demand in the Russian Federation for this vaccine has not yet been fully satisfied.
In August 2021, it was reported that the Chumakov Center is negotiating approval of the use of the CoviVak vaccine in Southeast Asia, as well as in Central and South America. Interest in the vaccine is high, but it is too early to talk about registering a vaccine abroad, the developers said.
In August 2021, the developers of CoviWaka also filed an application for preliminary approval of the drug in South Korea. At the same time, the country did not plan to purchase this vaccine.
The issue of recognition of the KoviVak coronavirus vaccine abroad is more political. This was announced on September 23, 2021 by the general director of the Chumakov Center Aidar Ishmukhametov.[1]KOVIVAK[2]
Notes
- ↑ v_nikaragua_anonsirovan_zapusk_proizvodstva_vakciny_kovivak LAUNCH OF
- ↑ VACCINE PRODUCTION ANNOUNCED IN NICARAGUA
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |